Trials / Unknown
UnknownNCT00563017
Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Hospital Authority, Hong Kong · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the efficacy, tolerability and safety of patients on long-acting Risperidone microshpheres injection. The major advantage of long-acting injection over oral medication is facilitation of compliance in medication taking. Non-compliance is very common among schizophrenic and is a frequent cause of relapse.
Conditions
- Schizophrenia, Catatonic
- Schizophrenia, Disorganized
- Schizophrenia, Paranoid
- Schizophrenia
- Psychotic Disorders
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Long-acting Risperidone microspheres injection |
Timeline
- Start date
- 2004-10-01
- Completion
- 2005-11-01
- First posted
- 2007-11-26
- Last updated
- 2010-07-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00563017. Inclusion in this directory is not an endorsement.